Update on RSV and New Vaccine Recommendation
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Help
Clear All

Query Builder

Query box

Help
Clear All

For additional assistance using the Custom Query please check out our Help Page

i

Update on RSV and New Vaccine Recommendation

Filetype[PDF-290.36 KB]


  • English
    • Details Supporting Files You May Also Like

    Details:

    • Corporate Authors:
      National Center for Immunization and Respiratory Diseases (U.S.)
    • Description:
      September 22, 2023, 5:00 PM EDT

      Key Takeaways

      • RSV season, which is typically in fall and winter, is right around the corner.

      • RSV activity has already started to increase in the Southeastern United States.

      • RSV can cause serious illness in infants, young children, and older adults. In fact, RSV is the leading reason that babies are hospitalized in the United States.

      • This year, we are in our strongest position ever with new RSV immunizations available to help protect babies, toddlers, and older adults from severe RSV. Most infants will likely only need protection from either the maternal RSV vaccine or the RSV immunization for babies, and not both.

      o Today, CDC recommended an RSV vaccine for people who are 32-36 weeks pregnant to protect their babies from severe RSV. The vaccine is recommended for seasonal use: in the continental US this generally means September through January. The seasonality of RSV season can vary, so state, local or territorial health departments may recommend different timing for administration for your area.

      o In August 2023, CDC recommended a new RSV immunization called nirsevimab to protect babies and some toddlers from severe RSV during the RSV season.

    • Subjects:
    • Document Type:
      Webpage
    • Place as Subject:
      United States
    • Collection(s):
    • Main Document Checksum:
    • Download URL:
    • File Type:

    Supporting Files

    More +

    You May Also Like

    Checkout today's featured content at stacks.cdc.gov